Regulation of the human papillomavirus type 18 E6/E6AP ubiquitin ligase complex by the HECT domain-containing protein EDD

Journal of Virology

Volumn 85, Issue 7, 2011, Pages 3120-3127

  Tomaić, Vjekoslav ^a   Pim, David ^a   Thomas, Miranda ^a   Massimi, Paola ^a   Myers, Michael P ^a   Banks, Lawrence ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN E6; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE E3; UBIQUITIN PROTEIN LIGASE EDD; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL STRAIN HEK293; CONTROLLED STUDY; EMBRYO; ENZYME REGULATION; ENZYME SUBSTRATE; GROWTH INHIBITION; HELA CELL; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 18; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN TARGETING; VIROGENESIS;

DNA-BINDING PROTEINS; HELA CELLS; HUMAN PAPILLOMAVIRUS 18; HUMANS; MASS SPECTROMETRY; ONCOGENE PROTEINS, VIRAL; PROTEIN INTERACTION MAPPING; PROTEIN MULTIMERIZATION; UBIQUITIN-PROTEIN LIGASES;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 18;

EID: 79952576973     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02004-10     Document Type: Article

References (46)

1. Banks, L., S. C. Barnett, and T. Crook. 1990. HPV-16 E7 functions at the G1 to S phase transition in the cell cycle. Oncogene 5:833-837.
2. Beer-Romero, P., S. Glass, and M. Rolfe. 1997. Antisense targeting of E6AP elevates p53 in HPV-infected cells but not in normal cells. Oncogene 14:595-602. (Pubitemid 27090962)
3. Boyer, S. N., D. E. Wazer, and V. Band. 1996. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res. 56:4620-4624. (Pubitemid 26338060)
4. Brimer, N., C. Lyons, and S. B. Vande Pol. 2007. Association of E6AP (UBE3A) with human papillomavirus type 11 E6 protein. Virology 358:303-310.
5. Callaghan, M. J., et al. 1998. Identification of a human HECT family protein with homology to the Drosophila tumor suppressor gene hyperplastic discs. Oncogene 17:3479-3491. (Pubitemid 29050683)
6. Camus, S., et al. 2007. Ubiquitin-independent degradation of p53 mediated by high-risk human papillomavirus protein E6. Oncogene 26:4059-4070. (Pubitemid 46920172)
7. Cavatorta, A. L., et al. 2004. Differential expression of the human homologue of drosophila discs large oncosuppressor in histologic samples from human papillomavirus-associated lesions as a marker for progression to malignancy. Int. J. Cancer 111:373-380. (Pubitemid 38998817)
8. Clancy, J. L., et al. 2003. EDD, the human orthologue of the hyperplastic discs tumour suppressor gene, is amplified and overexpressed in cancer. Oncogene 22:5070-5081. (Pubitemid 37026405)
9. Clayton-Smith, J., and L. Laan. 2003. Angelman syndrome: a review of the clinical and genetic aspects. J. Med. Genet. 40:87-95.
10. Cooper, K., C. S. Herrington, M. F. Evans, K. C. Gatter, and J. O. McGee. 1993. p53 antigen in cervical condylomata, intraepithelial neoplasia, and carcinoma: relationship to HPV infection and integration. J. Pathol. 171:27-34.
11. Gardiol, D., S. Galizzi, and L. Banks. 2002. Mutational analysis of the discs large tumour suppressor identifies domains responsible for human papillomavirus type 18 E6-mediated degradation. J. Gen. Virol. 83:283-289.
12. Gardiol, D., et al. 1999. Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation. Oncogene 18:5487-5496. (Pubitemid 29481495)
13. Grm, H. S., P. Massimi, N. Gammoh, and L. Banks. 2005. Crosstalk between the human papillomavirus E2 transcriptional activator and the E6 oncoprotein. Oncogene 24:5149-5164. (Pubitemid 41192432)
14. Hande, K. R. 1998. Etoposide: four decades of development of a topoisomerase II inhibitor. Eur. J. Cancer 34:1514-1521. (Pubitemid 28446331)
15. Helt, A. M., and D. A. Galloway. 2001. Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes. J. Virol. 75:6737-6747.
16. Henderson, M. J., et al. 2006. EDD mediates DNA damage-induced activation of CHK2. J. Biol. Chem. 281:39990-40000.
17. Henderson, M. J., et al. 2002. EDD, the human hyperplastic discs protein, has a role in progesterone receptor coactivation and potential involvement in DNA damage response. J. Biol. Chem. 277:26468-26478.
18. Honda, Y., et al. 2002. Cooperation of HECT-domain ubiquitin ligase hHYD and DNA topoisomerase II-binding protein for DNA damage response. J. Biol. Chem. 277:3599-3605.
19. Huh, K., et al. 2007. Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor. J. Virol. 81:9737-9747. (Pubitemid 350067678)
20. Huibregtse, J. M., M. Scheffner, and P. M. Howley. 1993. Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol. Cell. Biol. 13:775-784.
21. Huibregtse, J. M., M. Scheffner, and P. M. Howley. 1993. Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins. Mol. Cell. Biol. 13:4918-4927.
22. Kao, W. H., S. L. Beaudenon, A. L. Talis, J. M. Huibregtse, and P. M. Howley. 2000. Human papillomavirus type 16 E6 induces self-ubiquitination of the E6AP ubiquitin-protein ligase. J. Virol. 74:6408-6417.
23. Kelley, M. L., K. E. Keiger, C. J. Lee, and J. M. Huibregtse. 2005. The global transcriptional effects of the human papillomavirus E6 protein in cervical carcinoma cell lines are mediated by the E6AP ubiquitin ligase. J. Virol. 79:3737-3747.
24. Lie, A. K., S. Skarsvag, H. Skomedal, O. A. Haugen, and R. Holm. 1999. Expression of p53, MDM2, and p21 proteins in high-grade cervical intraepithelial neoplasia and relationship to human papillomavirus infection. Int. J. Gynecol. Pathol. 18:5-11.
25. Maddika, S., and J. Chen. 2009. Protein kinase DYRK2 is a scaffold that facilitates assembly of an E3 ligase. Nat. Cell Biol. 11:409-419.
26. Mantovani, F., and L. Banks. 2001. The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 20:7874-7887. (Pubitemid 33135314)
27. Mantovani, F., and L. Banks. 1999. Inhibition of E6 induced degradation of p53 is not sufficient for stabilization of p53 protein in cervical tumour derived cell lines. Oncogene 18:3309-3315. (Pubitemid 29286976)
28. Massimi, P., A. Shai, P. Lambert, and L. Banks. 2008. HPV E6 degradation of p53 and PDZ containing substrates in an E6AP null background. Oncogene 27:1800-1804. (Pubitemid 351380264)
29. Matlashewski, G., et al. 1987. Human papillomavirus type 16 DNA cooperates with activated ras in transforming primary cells. EMBO J. 6:1741-1746.
30. Mori, Y., et al. 2002. Instabilotyping reveals unique mutational spectra in microsatellite-unstable gastric cancers. Cancer Res. 62:3641-3645. (Pubitemid 34728839)
31. Münger, K., et al. 2001. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 20:7888-7898. (Pubitemid 33135315)
32. 2/M DNA damage checkpoints. Cell Cycle 6:3070-3077.
33. Nguyen, M., et al. 2002. A mutant of human papillomavirus type 16 E6 deficient in binding α-helix partners displays reduced oncogenic potential in vivo. J. Virol. 76:13039-13048. (Pubitemid 35386988)
34. Pim, D., P. Massimi, and L. Banks. 1997. Alternatively spliced HPV-18 E6* protein inhibits E6-mediated degradation of p53 and suppresses transformed cell growth. Oncogene 15:257-264. (Pubitemid 27370872)
35. Pim, D., A. Storey, M. Thomas, P. Massimi, and L. Banks. 1994. Mutational analysis of HPV-18 E6 identifies domains required for p53 degradation in vitro, abolition of p53 transactivation in vivo and immortalisation of primary BMK cells. Oncogene 9:1869-1876. (Pubitemid 24194152)
36. Scheffner, M., J. M. Huibregtse, R. D. Vierstra, and P. M. Howley. 1993. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75:495-505.
37. Tasaki, T., et al. 2005. A family of mammalian E3 ubiquitin ligases that contain the UBR box motif and recognize N-degrons. Mol. Cell. Biol. 25:7120-7136.
38. Thomas, J. T., and L. A. Laimins. 1998. Human papillomavirus oncoproteins E6 and E7 independently abrogate the mitotic spindle checkpoint. J. Virol. 72:1131-1137.
39. Thomas, M., et al. 2002. Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation. Oncogene 21:5088-5096.
40. Thomas, M., G. Matlashewski, D. Pim, and L. Banks. 1996. Induction of apoptosis by p53 is independent of its oligomeric state and can be abolished by HPV-18 E6 through ubiquitin mediated degradation. Oncogene 13:265-273. (Pubitemid 26334858)
41. Thomas, M., et al. 2008. Human papillomaviruses, cervical cancer and cell polarity. Oncogene 27:7018-7030.
42. Tomaić, V., et al. 2009. Human and primate tumour viruses use PDZ binding as an evolutionarily conserved mechanism of targeting cell polarity regulators. Oncogene 28:1-8.
43. Tomaić, V., D. Pim, and L. Banks. 2009. The stability of the human papillomavirus E6 oncoprotein is E6AP dependent. Virology 393:7-10.
44. Vasquez, R. J., B. Howell, A. M. Yvon, P. Wadsworth, and L. Cassimeris. 1997. Nanomolar concentrations of nocodazole alter microtubule dynamic instability in vivo and in vitro. Mol. Biol. Cell 8:973-985.
45. Vos, R. M., J. Altreuter, E. A. White, and P. M. Howley. 2009. The ubiquitin-specific peptidase USP15 regulates human papillomavirus type 16 E6 protein stability. J. Virol. 83:8885-8892.
46. zur Hausen, H. 1996. Papillomavirus infections - a major cause of human cancers. Biochim. Biophys. Acta 1288:F55-F78.